tm
Seeing Is Believing
tm
Seeing Is Believing
Cue Biopharma's activity chart (see below) currently has 36 price targets and 34 ratings on display.
Analysts average stock forecasts to be materialized ratio is 56.08% with an average time for these price targets to be met of 264.14 days.
Most recent stock forecast was given by from LUCID CAPITAL on 25-Aug-2025. First documented stock forecast 26-Jul-2019.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 25-Aug-2025
$4
$-21.39 (-84.25%)
1 years 1 months 12 days ago
(25-Aug-2025)
1/1 (100%)
$3.18 (387.80%)
242
Buy Since 22-Jan-2020
$2
$-23.39 (-92.12%)
$2
1 years 5 months 22 days ago
(15-Apr-2025)
7/7 (100%)
$1.2 (150.00%)
714
Buy Since 13-Mar-2024
$4
$-21.39 (-84.25%)
$6
1 years 10 months 22 days ago
(15-Nov-2024)
2/2 (100%)
$2.75 (220.00%)
649
Buy Since 09-Apr-2020
$4
$-21.39 (-84.25%)
$8
2 years 1 months 17 days ago
(20-Aug-2024)
4/4 (100%)
$3.14 (365.12%)
700
Buy Since 21-Nov-2022
$3
$-22.39 (-88.18%)
$3
2 years 1 months 17 days ago
(20-Aug-2024)
5/5 (100%)
$2.14 (248.84%)
839
What is CUE (Cue Biopharma) average time for price targets to be met?
Which analyst most recently updated their price target on CUE (Cue Biopharma)?
Which analyst has the most public recommendations on CUE (Cue Biopharma)?
Which analyst is the currently most bullish on CUE (Cue Biopharma)?
Which analyst is the currently most reserved on CUE (Cue Biopharma)?
